SCHEMBL168355

SCHEMBL168355

[CH2]CCCCCC(C(=O)O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.39
GPR84 Q9NQS5 3/20 0.38
FFAR1 O14842 1/20 0.38
MAPT P10636 1/20 0.37
LCK P06239 1/20 0.37
PPARD Q03181 1/20 0.37
ZDHHC20 Q5W0Z9 1/20 0.37
ZDHHC2 Q9UIJ5 1/20 0.37
GSR P00390 1/20 0.34
ENPEP Q07075 1/20 0.34
CPB2 Q96IY4 2/20 0.34
ACE2 Q9BYF1 1/20 0.34
RNPEP Q9H4A4 1/20 0.33
FOLH1 Q04609 1/20 0.33
GRIK1 P39086 1/20 0.31
GRIK2 Q13002 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL165661 1.00 TBXAS1 (0.39) TBXAS1GPR84FFAR1MAPTLCK
SCHEMBL27856541 1.00 TBXAS1 (0.39) TBXAS1GPR84FFAR1MAPTLCK
SCHEMBL168046 1.00 TBXAS1 (0.39) TBXAS1GPR84FFAR1MAPTLCK
SCHEMBL27574099 1.00 TBXAS1 (0.39) TBXAS1GPR84FFAR1MAPTLCK
SCHEMBL168927 1.00 TBXAS1 (0.39) TBXAS1GPR84FFAR1MAPTLCK
SCHEMBL167930 0.97 TBXAS1 (0.36) TBXAS1GPR84FFAR1MAPTLCK
SCHEMBL165787 0.89 ENPEP (0.37) TBXAS1GPR84FFAR1GSRENPEP
SCHEMBL30018584 0.86 GPR84 (0.46) TBXAS1GPR84FFAR1MAPTLCK
SCHEMBL30018402 0.86 GPR84 (0.46) TBXAS1GPR84FFAR1MAPTLCK
SCHEMBL9009694 0.86 GPR84 (0.46) TBXAS1GPR84FFAR1MAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1080 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101331143-A Hypophosphorous acid derivatives and their therapeutic use CENTRE NAT RECH SCIENT (FR) 2008-12-24 CN claimed
EP-4381345-A1 SWITCHING LAYERS FOR USE IN A WINDOW ELEMENT Merck Patent GmbH (DE) 2024-06-12 EP disclosed
EP-3704176-B1 ORGANIC SEMICONDUCTING COMPOUNDS RAYNERGY TEK INC (TW) 2024-05-15 EP disclosed
US-20240134218-A1 DEVICE FOR THE REGULATION OF LIGHT TRANSMISSION MERCK PATENT GMBH (DE) 2024-04-25 US disclosed
US-11958819-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2024-04-16 US disclosed
US-11952528-B2 Switching layers for use in a switching element MERCK PATENT GMBH (DE) 2024-04-09 US disclosed
EP-3794650-B1 ORGANIC SEMICONDUCTORS RAYNERGY TEK INC (TW) 2024-03-13 EP disclosed
CN-107915661-B Organic semiconductor compound 天光材料科技股份有限公司 2024-01-23 CN disclosed
CN-108148073-B Organic semiconductor compound 天光材料科技股份有限公司 2023-12-08 CN disclosed
US-11839155-B2 Organic semiconducting compounds RAYNERGY TEK INC. (TW) 2023-12-05 US disclosed
US-5045229-A Liquid crystals MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1991-09-03 US disclosed
WO-1991012234-A2 DIFLUOROACETONITRILE DERIVATIVES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-08-22 WO disclosed
WO-1991011418-A1 PARTIALLY FLUORINATED COMPOUNDS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-08-08 WO disclosed
WO-1991008184-A2 1,2-DISUBSTITUTED 2,6-DIFLUOROBENZENE COMPOUNDS AND LIQUID CRYSTAL MEDIA MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-06-13 WO disclosed
WO-1991003450-A1 FLUOROBENZOLE DERIVATIVES AND MESOMORPHOUS MEDIUM MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-03-21 WO disclosed
EP-0381728-A1 DIFLUOROMETHYL COMPOUNDS. MERCK PATENT GMBH (DE) 1990-08-16 EP disclosed
US-4925590-A Derivatives of 4-cyano-2,3-difluorophenol MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1990-05-15 US disclosed
WO-1990001056-A1 DIFLUOROMETHYL COMPOUNDS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1990-02-08 WO disclosed
EP-0329752-A1 FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS MERCK PATENT GmbH (DE) 1989-08-30 EP disclosed
WO-1989002425-A1 FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1989-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11839155-B2 Organic semiconducting compounds OCIAD2, OCIAD1, OSTC TBXAS1 1437/4885GPR84 3560/4885FFAR1 4065/4885
US-11958819-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A TBXAS1 678/4885GPR84 2230/4885FFAR1 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.